Holen Sie sich die Stockscreener-App
49.32
0.06%
-0.03
Schlusskurs vom Vortag:
$49.35
Offen:
$49.5
24-Stunden-Volumen:
654.83K
Relative Volume:
0.55
Marktkapitalisierung:
$10.70B
Einnahmen:
$2.04B
Nettoeinkommen (Verlust:
$373.39M
KGV:
29.08
EPS:
1.6961
Netto-Cashflow:
$495.96M
1W Leistung:
+2.18%
1M Leistung:
+9.43%
6M Leistung:
+14.54%
1J Leistung:
+15.26%
1-Tages-Spanne:
$49.06
$49.53
1-Wochen-Bereich:
$48.15
$49.59
52-Wochen-Spanne:
$37.74
$51.88
Qiagen Nv Stock (QGEN) Company Profile
Firmenname
Qiagen Nv
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie QGEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
49.32 | 10.70B | 2.04B | 373.39M | 495.96M | 1.6961 |
|
TMO
Thermo Fisher Scientific Inc
|
572.50 | 215.96B | 43.74B | 6.59B | 6.11B | 17.30 |
|
DHR
Danaher Corp
|
223.01 | 157.33B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
640.85 | 51.09B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
148.03 | 41.80B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
220.52 | 37.38B | 15.70B | 1.24B | 2.01B | 6.9036 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-24 | Eingeleitet | Barclays | Overweight |
| 2025-04-04 | Herabstufung | Redburn Atlantic | Buy → Neutral |
| 2025-02-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-01-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-12-10 | Hochstufung | Jefferies | Hold → Buy |
| 2024-10-17 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-06-27 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-12-07 | Hochstufung | Goldman | Neutral → Buy |
| 2023-09-12 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-05-23 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-01-18 | Hochstufung | DZ Bank | Hold → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-10-14 | Eingeleitet | Redburn | Buy |
| 2021-07-14 | Herabstufung | Kepler | Buy → Hold |
| 2021-06-03 | Eingeleitet | Goldman | Neutral |
| 2020-10-06 | Fortgesetzt | BofA Securities | Buy |
| 2020-09-28 | Hochstufung | Kepler | Hold → Buy |
| 2020-08-24 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
| 2020-08-17 | Hochstufung | Berenberg | Hold → Buy |
| 2020-08-14 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-08-14 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-04 | Herabstufung | Berenberg | Buy → Hold |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-12-26 | Fortgesetzt | BofA/Merrill | Underperform |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-11-14 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-11-14 | Hochstufung | JP Morgan | Underweight → Overweight |
| 2019-11-14 | Hochstufung | Kepler | Reduce → Hold |
| 2019-10-17 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2019-10-09 | Herabstufung | Kepler | Hold → Reduce |
| 2019-10-08 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-10-08 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2019-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
Alle ansehen
Qiagen Nv Aktie (QGEN) Neueste Nachrichten
Is Qiagen N.V. stock a safe haven assetMarket Growth Review & Low Volatility Stock Recommendations - newser.com
Can Qiagen N.V. stock sustain free cash flow growthWeekly Risk Summary & Community Verified Trade Signals - newser.com
How Qiagen N.V. Common Shares stock trades after rate cutsQuarterly Trade Summary & Growth Focused Entry Point Reports - newser.com
Can Qiagen N.V. stock hit record highs again2025 Short Interest & Target Return Focused Stock Picks - newser.com
Regression analysis insights on Qiagen N.V. performanceJuly 2025 Momentum & Risk Adjusted Swing Trade Ideas - newser.com
How to integrate Qiagen N.V. into portfolio analysis toolsWeekly Profit Report & Verified Trade Idea Suggestions - newser.com
Is Qiagen N.V. (QIA) stock overpriced at current multiplesInsider Selling & Stepwise Trade Execution Plans - newser.com
Will Qiagen N.V. (QIA) stock keep high P E multiplesLayoff News & Accurate Intraday Trading Signals - newser.com
Using portfolio simulators with Qiagen N.V. included2025 Short Interest & Community Consensus Picks - newser.com
What valuation ratios show for Qiagen N.V. Common Shares stock2025 Geopolitical Influence & Consistent Profit Trade Alerts - newser.com
What to expect from Qiagen N.V. in the next 30 days2025 Earnings Surprises & Stepwise Entry and Exit Trade Signals - newser.com
Will breakout in Qiagen N.V. lead to full recoveryJuly 2025 Outlook & Long Hold Capital Preservation Plans - newser.com
Qiagen (NYSE:QGEN): Assessing Valuation After Recent Share Price Rebound - simplywall.st
Published on: 2025-10-24 20:25:15 - newser.com
Bank of America Discloses Significant Indirect Holdings in QIAGEN - TipRanks
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
Release according to Article 40, Section 1 of the WpHG - TradingView
Sector Gamma AS Trims Stock Position in Qiagen N.V. $QGEN - MarketBeat
Finanzdaten der Qiagen Nv-Aktie (QGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.57%
1.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):